During the past decade, Instituto centenario conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto centenario" are "Rheumatoid Arthritis" (3 trials), "Type 2 Diabetes" (3 trials), "Duchenne Muscular Dystrophy" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Instituto centenario" in a lesser frequency.

Most popular intervention types in "Instituto centenario" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GDC-0853" (2 trials), "Insulin Efsitora Alfa" (2 trials), "Insulin Glargine (U100)" (2 trials) and "Insulin Lispro (U100)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto centenario" are 9 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto centenario". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto centenario, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto centenario, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".